2021
|
|
|
Capicua transcriptional repressor pseudogene 7 |
- |
Curated: N/A
Unreviewed: N/A
|
2022
|
|
|
Capicua transcriptional repressor pseudogene 8 |
- |
Curated: N/A
Unreviewed: N/A
|
2023
|
|
|
Capicua transcriptional repressor pseudogene 9 |
- |
Curated: N/A
Unreviewed: N/A
|
2024
|
|
|
Cell death inducing DFFA like effector a |
CIDE-A |
Curated: Attention deficit hyperactivity disorder, Congestive heart failure, Heart failure, Liver neoplasms, Obesity
Unreviewed: Atopic dermatitis, Breast neoplasm, Congestive Heart Failure, Diabetes Mellitus, Diabetes mellitus, type 2, Endometrial carcinoma, Endometrial neoplasm, Heart Failure, Hypertrophy, Liver Cancer, Metabolic Syndrome, Myocardial Infarction, Myotonic dystrophy, Non-Alcoholic Fatty Liver Disease, Stomach neoplasms
|
2025
|
|
|
Cell death inducing DFFA like effector b |
- |
Curated: Anorectal malformation
Unreviewed: Coronary artery disease, Obesity, Renal cell carcinoma
|
2026
|
|
|
Cell death inducing DFFA like effector c |
CIDE-3, CIDE3, FPLD5, FSP27 |
Curated: Familial partial lipodystrophy, Allergic contact dermatitis, Partial lipodystrophy, Lipodystrophy
Unreviewed: Acanthosis Nigricans, Arteriosclerosis, Atherosclerosis, Breast neoplasm, Carcinogenesis, Dermatitis, Diabetes, Diabetes Mellitus, Dyslipidemias, Fatty Liver, Insulin-resistant diabetes mellitus, Leiomyoma, Liver Fibrosis, Lung adenocarcinoma, Macular degeneration, Metabolic Diseases, Metabolic Syndrome, Myotonic dystrophy, Neoplasms, Non-Alcoholic Fatty Liver Disease, Obesity, Pancreatitis, Partial Lipodystrophy, Polycystic Ovary Syndrome, Renal cell carcinoma, Septal Hypertrophy, Squamous cell carcinoma, Stomach neoplasms, Triple negative breast cancer
|
2027
|
|
|
CIDEC pseudogene 1 |
CICE, CIDECP |
Curated: N/A
Unreviewed: N/A
|
2028
|
|
|
- |
- |
Curated: N/A
Unreviewed: N/A
|
2029
|
|
|
Class II major histocompatibility complex transactivator |
C2TA, CIITAIV, MHC2D1, MHC2TA, NLRA |
Curated: Rheumatoid arthritis, Asthma, Eczema, Bare lymphocyte syndrome, Celiac disease, Crohn disease, Gastro-entero-pancreatic neuroendocrine tumor, Inflammatory bowel disease, Juvenile idiopathic arthritis, Systemic lupus erythematosus, Multiple sclerosis, Myocardial infarction, Nasopharyngeal neoplasms, Oligoarticular juvenile idiopathic arthritis, Ulcerative colitis, MHC class II deficiency
Unreviewed: Addison`s Disease, Agammaglobulinemia, Amyotrophic lateral sclerosis, Anodontia, Antithrombin deficiency, Arthritis, Astrocytoma, Atherosclerosis, Autoimmune disease, Autoimmune Diseases, Autoimmune hemolytic anemia, B-Cell Lymphoma, Bare Lymphocyte Syndrome, Behcet disease, Behcet Syndrome, Bone disease, Breast neoplasm, Carcinoma, Cholangitis, Choriocarcinoma, Colitis, Colorectal Cancer, Colorectal neoplasm, Complete Atrioventricular Block, Coronary Syndrome, Diabetes Mellitus, Diabetes mellitus, type 2, Diffuse Lymphoma, Digestive system neuroendocrine neoplasm, Drachtman Weinblatt Sitarz syndrome, Duchenne muscular dystrophy, Dysarthria, Encephalitis, Eosinophilia, Fanconi Anemia, Gastrointestinal Neoplasms, Glioma, Granulomatosis With Polyangiitis, Hematopoietic Neoplasms, Hemolytic anemia, Hodgkin Disease, Immune Thrombocytopenic Purpura, Immunologic Deficiency Syndromes, Inflammatory Bowel Disease, Insulinoma, Ischemic Stroke, Leprosy, Leukemia, Liver carcinoma, Lupus Erythematosus, Lupus Vulgaris, Lymphoma, Malabsorption Syndrome, Malignant Neoplasm, Melanoma, Metabolic Syndrome, Mitral Valve Stenosis, Mouth disease, Multiple myeloma, Multiple Sclerosis, Myeloid leukemia, Myocardial Infarction, Myositis, Narcolepsy, Nasal polyposis, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Neoplasms, Neuroblastoma, Neutropenia, Osteopenia, Osteoporosis, Otitis media, Pancreatic neoplasm, Pancytopenia, Prostatic neoplasm, Rectal Neoplasms, Renal Carcinoma, Renal cell carcinoma, Rhabdomyosarcoma, Rhinitis, Sarcoidosis, Severe combined immunodeficiency, Sinusitis, Small cell lung carcinoma, Stomach neoplasms, Testicular germ cell tumor, Thymoma, Urinary bladder neoplasms, Uveal Melanoma, Vasculitis, Vitiligo, Vitiligo-associated SYSTEMIC LUPUS ERYTHEMATOSUS
|
2030
|
|
|
- |
- |
Curated: N/A
Unreviewed: N/A
|